SEPTInvestingStart Free

CABA 8-K: Fda approval

Filed with the SEC on · accession 0001759138-26-000050

CABA filed a 8-K (current report) with the SEC on Nov 9, 2026. Cabaletta Bio presented new positive Phase 1/2 clinical data for rese-cel (resecabtagene autoleucel) across multiple autoimmune diseases at ACR Convergence 2026, showing durable immunomodulator-free responses and a favorable benefit-risk profile.

Summary of the filing

Cabaletta Bio presented new positive Phase 1/2 clinical data for rese-cel (resecabtagene autoleucel) across multiple autoimmune diseases at ACR Convergence 2026, showing durable immunomodulator-free responses and a favorable benefit-risk profile. The company also updated its corporate presentation and reiterated plans for a BLA submission in myositis in Q1 2028.

For details, click here →How to read a 8-K →

Key details

RegistrantCabaletta Bio, Inc.

✦ Ask GOAX AI about this filing — what it means for CABA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CABA?

Click here

Frequently asked questions

What did CABA file with the SEC on Nov 9, 2026?

CABA filed a 8-K (Fda approval). Cabaletta Bio presented new positive Phase 1/2 clinical data for rese-cel (resecabtagene autoleucel) across multiple autoimmune diseases at ACR Convergence 2026, showing durable immunomodulator-free responses and a favorable benefit-risk profile. The company also updated its corporate presentation and reiterated plans for a BLA submission in myositis in Q1 2028.

What does a fda approval mean for CABA stock?

For a small biotech one drug can be most of the company’s value. Approval opens sales; a rejection (complete response letter) can delay it by years.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other CABA SEC filings

Get alerts when CABA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
CABA overviewCABA analysisCABA newsLatest SEC filings